Innoviva Inc (INVA)
15.16
+0.23
(+1.54%)
USD |
NASDAQ |
Apr 23, 16:00
15.16
0.00 (0.00%)
After-Hours: 20:00
Innoviva Debt to Equity Ratio: 0.6611 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.6611 |
September 30, 2023 | 0.7103 |
June 30, 2023 | 0.802 |
March 31, 2023 | 0.792 |
December 31, 2022 | 0.9551 |
September 30, 2022 | 0.8417 |
June 30, 2022 | 1.389 |
March 31, 2022 | 1.393 |
December 31, 2021 | 0.9516 |
September 30, 2021 | 0.9739 |
June 30, 2021 | 1.183 |
March 31, 2021 | 0.6111 |
December 31, 2020 | 0.714 |
September 30, 2020 | 0.7895 |
June 30, 2020 | 0.8344 |
March 31, 2020 | 0.999 |
December 31, 2019 | 1.203 |
September 30, 2019 | 1.455 |
June 30, 2019 | 1.706 |
March 31, 2019 | 2.044 |
December 31, 2018 | 2.493 |
September 30, 2018 | -3.421 |
June 30, 2018 | -3.092 |
March 31, 2018 | -2.269 |
December 31, 2017 | -2.468 |
Date | Value |
---|---|
September 30, 2017 | -2.706 |
June 30, 2017 | -2.204 |
March 31, 2017 | -2.122 |
December 31, 2016 | -2.029 |
September 30, 2016 | -1.965 |
June 30, 2016 | -1.998 |
March 31, 2016 | -2.029 |
December 31, 2015 | -2.140 |
September 30, 2015 | -2.304 |
June 30, 2015 | -2.512 |
March 31, 2015 | -2.814 |
December 31, 2014 | -3.249 |
September 30, 2014 | -3.651 |
June 30, 2014 | -3.933 |
March 31, 2014 | 1.092 |
December 31, 2013 | 0.9611 |
September 30, 2013 | 0.8711 |
June 30, 2013 | 5.370 |
March 31, 2013 | 5.027 |
December 31, 2012 | 1.113 |
September 30, 2012 | 0.9955 |
June 30, 2012 | 0.9115 |
March 31, 2012 | 28.14 |
December 31, 2011 | -1.982 |
September 30, 2011 | -2.918 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6111
Minimum
Mar 2021
1.706
Maximum
Jun 2019
0.9981
Average
0.9516
Median
Dec 2021
Debt to Equity Ratio Benchmarks
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.244B |
Total Liabilities (Quarterly) | 568.55M |
Shareholders Equity (Quarterly) | 674.96M |
Current Ratio | 9.027 |
Net Debt Paydown Yield | 1.84% |